# NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £31,584,025
- Published: 25 January 2023
- Planned start: 1 May 2023
- Planned end: 1 January 2025
- Stage: open_tender
- Procurement category: goods
- Notice ID: 005e9609-bbe8-42f8-bbab-90ee2e98dec0-608772
- OCID: ocds-b5fd17-8d752e46-555e-439d-bd07-d486104ff716

## Description

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER \(FTS\) Reference number Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 48 months\. Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 - 30/04/2024 - \(12 Months\) LSNE 01/05/2023 - 30/04/2024 - \(12 Months\) NWLN 01/05/2023 - 30/04/2024 - \(12 Months\) CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 - 31/05/2024 \(13 Months\) NWLN 01/05/2023 - 31/01/2025 \(21 months\)

## Related contract awards

- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [Provision of national e-portfolio 26/27](/contracts/ocds-b5fd17-7e027849-39ea-4eb8-8eb0-3b38f18dcca4): NHS England
- [D&A Platform Run & Maintain](/contracts/ocds-b5fd17-58fe109d-49a3-4eea-957d-31f6bd69ff81): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/005e9609-bbe8-42f8-bbab-90ee2e98dec0-608772)